Prem S. Shah - Apr 1, 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role: EVP and Co-President of Retail
Signature: /s/ Prem S. Shah
Stock symbol: CVS
Transactions as of: Apr 1, 2023
Transactions value $: $6,379,662
Form type: 4
Date filed: 4/4/2023, 04:36 PM
Previous filing: Mar 1, 2023
Next filing: Sep 1, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CVS	Common Stock	Tax liability	-$239K	-3.22K	-6.13%	$74.31	49.4K	Apr 1, 2023	Direct	F1
holding	CVS	Common Stock (pep)						4.52K	Apr 1, 2023	Direct
holding	CVS	Common Stock (Restricted)						29.6K	Apr 1, 2023	Direct
holding	CVS	ESOP Common Stock						4.67K	Apr 1, 2023	Direct
holding	CVS	Stock Unit (deferred)						7.76K	Apr 1, 2023	Direct	F2

Showing 1 to 5 of 5 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVS	Stock Option	Award	$6.62M	+89.1K		$74.31	89.1K	Apr 1, 2023	Common Stock	89.1K	$74.31	Direct	F12
holding	CVS	Phantom Stock Credits						12.2K	Apr 1, 2023	Common Stock	12.2K	$1.00	Direct	F3, F4
holding	CVS	Stock Option						2.94K	Apr 1, 2023	Common Stock	2.94K	$104.82	Direct	F5
holding	CVS	Stock Option						846	Apr 1, 2023	Common Stock	846	$62.21	Direct	F6
holding	CVS	Stock Option						9.47K	Apr 1, 2023	Common Stock	9.47K	$54.19	Direct	F7
holding	CVS	Stock Option						28.6K	Apr 1, 2023	Common Stock	28.6K	$58.34	Direct	F8
holding	CVS	Stock Option						26.6K	Apr 1, 2023	Common Stock	26.6K	$75.24	Direct	F9
holding	CVS	Stock Option						28.7K	Apr 1, 2023	Common Stock	28.7K	$74.30	Direct	F10
holding	CVS	Stock Option						41.6K	Apr 1, 2023	Common Stock	41.6K	$101.09	Direct	F11

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.
F2	Consists of Stock Units awarded pursuant to Issuer's 2010 & 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer.
F3	Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F4	Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F5	Option became exercisable in four equal installments commencing 04/01/2017.
F6	Option became exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised.
F7	Option became exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised
F8	Option became exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised.
F9	Option vests in three equal installments, on 8/31/2021, 8/31/2022 and 8/31/2023.
F10	Option became exercisable in three equal installments commencing 04/01/2022.
F11	Option became exercisable in four equal installments, commencing 4/1/2023.
F12	Option becomes exercisable in four equal annual installments, commencing 4/1/2024.